← FDA DRUG APPROVALS

FDA NDA · NDA021738

EXTINA

Sponsor: RISING

APPLICATION
NDA021738
TYPE
NDA
ORIGINAL APPROVAL
2007-06-12
LATEST ACTION
2018-06-20
ROUTE
TOPICAL
DOSAGE FORM
AEROSOL, FOAM
MARKETING STATUS
Discontinued

Products

EXTINA · ReferenceDiscontinued
KETOCONAZOLE 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · AEROSOL, FOAM · TOPICAL

Approval history

2018-06-20Labeling · Supplement 7 · standard — Label ↗AP
2007-06-12Type 3 - New Dosage Form · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →